Showing 2611-2620 of 5617 results for "".
- Navigated TMS Added To Psychotherapy Reduced PTSD Symptomshttps://reachmd.com/news/navigated-tms-added-to-psychotherapy-reduced-ptsd-symptoms/2486564/Investigators observed that navigated TMS, when added to psychotherapy, was linked with
- Navigated TMS Trial Reports PTSD Symptom Improvementhttps://reachmd.com/news/navigated-tms-ptsd-symptom-improve/2486556/Key Takeaways Adjunctive navigated TMS was associated with greater reported PTSD symptom improvement than sham in this randomized trial population. Improvement was reported at one month, and group differences were also reported at three months. </
- CLL Linked to Higher Skin Cancer Risk and Worse Outcomes in Nationwide Studyhttps://reachmd.com/news/cll-linked-to-higher-skin-cancer-risk-and-worse-outcomes-in-nationwide-study/2486526/Patients with chronic lymphocytic leukemia (CLL) face a significantly elevated risk of developing skin cancer, according to a nationwide Danish cohort study spanning three decades. Study investigators analyzed registry data fr
- Nanotechnology Meets Traditional Medicine: Emerging Strategies to Improve Wound Healing Outcomeshttps://reachmd.com/news/nanotechnology-meets-traditional-medicine-emerging-strategies-to-improve-wound-healing-outcomes/2486473/Key Takeaways Nanocarrier systems significantly enhance the stability, bioavailability, and skin penetration of T
- Rapid Fluid Resolution and Faricimab Durability in nAMD: TENAYA/LUCERNE Post Hoc Findingshttps://reachmd.com/news/rapid-fluid-resolution-and-faricimab-durability-in-namd-tenayalucerne-post-hoc-findings/2486316/In nAMD trials that use interval-assignment algorithms, a recurring question is whether early “drying” on optical coherence tomography relates to later dosing durability. In a post hoc analysis of treatment-naive nAMD participants treated with faricimab in
- Gadolinium Nanoparticles: Design, Theranostic Functionality, and Translational Barriershttps://reachmd.com/news/gadolinium-nanoparticles-design-theranostic-functionality-and-translational-barriers/2486066/Gadolinium nanoparticles are described in a 2026 Pharmaceutics review as theranostic platforms that pair MRI visibility with therapeutic functio
- Coating-Dependent Biodistribution of Magnetite Nanoparticleshttps://reachmd.com/news/coating-dependent-biodistribution-of-magnetite-nanoparticles/2486030/An in vivo comparison of magnetite nanoparticles with multiple surface coatings quantified circulation kinetics and organ biodistribution using magnetic particle quantification (MPQ), with readou
- MDA Research Momentum Award: Łukasz Sznajder Named Inaugural Recipienthttps://reachmd.com/news/mda-research-momentum-award-ukasz-sznajder-named-inaugural-recipient/2485905/In a press release, the Muscular Dystrophy Association (MDA) announced that Łukasz Sznajder, PhD, MSc, an assistant professor in the Department of Chemistry and Biochemistry at the University of Nevada, Las Vegas, has been named the first recipient of its new
- Triple‑Phytochemical Nanoparticle for CRC: Formulation, In Vitro Release, Safety, and Gene‑Expression Signalshttps://reachmd.com/news/triplephytochemical-nanoparticle-for-crc-formulation-in-vitro-release-safety-and-geneexpression-signals/2485787/Investigators report developing a triple-payload nanoparticle carrying resveratrol, acetyl-11-keto-β-boswellic acid (AKBA), and quercetin—referred to as the 3X nanoparticle formulation—for colore
- Antigen Arrangement Alters CD8 Responses in an SNA HPV Nanovaccinehttps://reachmd.com/news/antigen-arrangement-alters-cd8-responses-in-an-sna-hpv-nanovaccine/2485751/The spherical nucleic acid (SNA) nanovaccine was reported to generate different CD8+ T-cell responses and tumor-related outcomes when an HPV-derived peptide was repositioned within the